Mapping of Patents Related to The Development of Products for Diabetic Neuropathy: a technological prospection from 2010 to 2022
DOI:
https://doi.org/10.33448/rsd-v11i6.29022Keywords:
Diabetes Mellitus; Diabetic neuropathies; Technology.Abstract
Diabetic neuropathy is a complication of diabetes that occurs in 40-60 million diabetics worldwide and is associated with other chronic diseases. Besides that, there are no prospective studies that present the state of the technique about technologies developed to circumvent this important public health problem. Given the above, this study aims to carry out a technological prospection about the products developed for diabetic neuropathy in the period 2010-02/02/2022. To this end, a technological prospection was carried out at the INPI and ESPACENET patent office’s always making a parallel between Brazilian reality in comparison with international companies. Therefore, in this period, it was found that the countries that produced the most patents on the subject were China, the United States, and Japan, and the company that published the most patents in this period was Beijing Luyuan Qiuzheng Technology Dev. Co Ltd. Thus, the data from this study showed that Brazil did not produce patents on the subject in this period and that China, the United States, and Japan were the countries that showed the greatest interest in technological development aimed at this disease, which affects millions of people all over the world.
References
Acioli, G. D. R., & Oliveira Júnior, A. M. (2014). Prospecção tecnológica sobre a cura do Diabetes Mellitus.
Altiere, C. E. (2017). Neuropatia periférica causa perda da sensibilidade e formigamento. Retrieved from https://www.hospitalsiriolibanes.org.br/sua-saude/Paginas/neuropatia-periferica-causa-perda-sensibilidade-formigamento
Amparo, K. K. D. S., Ribeiro, M. D. C. O., & Guarieiro, L. L. N. (2012). Case study using mapping technology foresight as the main tool of scientific research. Perspectivas em Ciencia da Informacao, 17, 195-209.
Anad. (2020). O que saber sobre neuropatia por pequenas fibras. Retrieved from https://www.anad.org.br/o-que-saber-sobre-neuropatia-por-pequenas-fibras/
Armstrong, DG, Boulton, AJ, & Bus, SA (2017).Úlceras do pé diabético e sua recorrência.New England Journal of Medicine,376 (24), 2367-2375.
Baum, P., Toyka, KV, Blüher, M., Kosacka, J., & Nowicki, M. (2021). Mecanismos Inflamatórios na Fisiopatologia da Neuropatia Periférica Diabética (ND)—Novos Aspectos. International Journal of Molecular Sciences , 22 (19), 10835.
Boeck J. A. (2019). A Prospecção Tecnologica como Estratégia Competitiva para inovarmos Retrieved from https://neitzkeconsultoria.com/prospeccao-tecnologica/
Boehm, M., Crawford, M., Moscovitz, JE, & Carpino, PA (2018). Análise de participação de patentes na área de diabetes – parte II: anos 2011-2016. Opinião de Especialista em Patentes Terapêuticas , 28 (2), 111-122.
Brazil. (2013a). Brazil’S Patent Reform: INNOVATION TOWARDS NATIONAL COMPETITIVENESS. Retrieved from https://www2.camara.leg.br/a-camara/estruturaadm/altosestudos/pdf/brazils_patent_reform_eng.pdf
Brazil. (2013b).Lei de patentes 9279/1996. A revisão da Lei de patentes: inovação em prol da competitividade nacional.
Brazil (2019) Resolução INPI PR nº 240, de 03 de julho de 2019
Brazil (2019) Resolução INPI PR nº 241, de 03 de julho de 2019
Brazil (2021) Portaria INPI PR nº 21, de 26 de março de 2021,(2021).
CF, M. R. D. M. (2020). Competitive intelligence, innovation and performance: theoretical model proposal. Braz. J. of Develop, 6(1), 657-678.
Correr, C. J., Coura-Vital, W., Frade, J. C. Q. P., Nascimento, R. C. R. M., Nascimento, L. G., Pinheiro, E. B., João, W. S. J. (2020). Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil. Diabetology & Metabolic Syndrome, 12(1), 89. doi:10.1186/s13098-020-00593-5
Federation, I.-I. D. (2021). The Diabetes Atlas. Retrieved from
https://www.idf.org/news/240:diabetes-now-affects-one-in-10-adults-worldwide.html
Galindo, R. J., & Aleppo, G. (2020). Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pract, 170, 108502. doi:10.1016/j.diabres.2020.108502
Hicks, C. W., & Selvin, E. (2019). Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep, 19(10), 86. doi:10.1007/s11892-019-1212-8
IDF. (2021). Diabetes now affects one in 10 adults worldwide. Retrieved from https://www.idf.org/news/240:diabetes-now-affects-one-in-10-adults-worldwide.
INPI. (2021). Classificação Patentes. Retrieved from https://www.gov.br/inpi/pt-br
Kruk, M. E., Gage, A. D., Arsenault, C., Jordan, K., Leslie, H. H., Roder-DeWan, S., Pate, M. (2018). High-quality health systems in the Sustainable Development Goals era: time for a revolution. The Lancet Global Health, 6(11), e1196-e1252. doi:10.1016/S2214-109X(18)30386-3
Lee, S. H., & Yoon, K. H. (2021). A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future. Diabetes Metab J, 45(5), 629-640. doi:10.4093/dmj.2021.0163
Liu, X. (2012). Traditional chinese medicine for curing diabetic peripheral neuropathy, number CN102389503, 2012-jun-07.
MINAYO, M. C. S. (1994) (org.) Pesquisa social: teoria, método e criatividade. Petrópolis – Rio de Janeiro, Vozes.
Ministério da Saúde. (2020). Vigitel 2020: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. Transinf, 102-104.
OECD. (2015). Education at a Glance 2015.
ONU. (2021). 100 anos depois, 50% dos diabéticos ainda enfrentam barreiras no acesso à insulina. Retrieved from https://news.un.org/pt/story/2021/11/1770212
Sarwar, N., Gao, P., Seshasai, S. R., Gobin, R., Kaptoge, S., Di Angelantonio, E., . . . Danesh, J. (2010). Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 375(9733), 2215-2222. doi:10.1016/s0140-6736(10)60484-9
Singh, VP, Bali, A., Singh, N., & Jaggi, AS (2014). Produtos finais de glicação avançada e complicações diabéticas.O jornal coreano de fisiologia e farmacologia18 (1), 1-14
Who. (2021). 100 years after its discovery, insulin still out of reach for many living with diabetes. Retrieved from https://www.who.int/news/item/12-11-2021-new-who-report-maps-barriers-to-insulin-availability-and-suggests-actions-to-promote-universal-access
Zhu, W., Huang, W., Xu, Z., Cao, M., Hu, Q., Pan, C., . . . Yuan, H. (2019). Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus. Frontiers in Pharmacology, 10. doi:10.3389/fphar.2019.00586
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Giselda dos Santos Barros; Hilton Henrique Cruz Santos Pereira; Maria Suely Regis Souza; Maria Emília Camargo; Paula dos Passos Menezes; Gabriel Francisco da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
